Singapore based company Neuome Peptides Pte Ltd, a start-up backed by Mercatus Capital Singapore has developed a Peptide-based rapid antigen test kit, TruCov-Flow. This technology detects SARS-CoV-2 virus from saliva thus removing the need for swab and results come within 3-5 minutes maximum. It is ICMR validated and approved